273
Views
15
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Novel (pandemic) influenza A H1N1 in healthcare facilities: Implications for prevention and control

Pages 412-420 | Received 12 Jan 2010, Accepted 13 Feb 2010, Published online: 24 Mar 2010

References

  • Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003;55:83–91.
  • Schnitzler SU, Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009;39:279–92.
  • Novel Swine-origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:102.
  • World Health Organization. Pandemic (H1N1) 2009—Update 86, weekly update. Geneva: WHO; 2009. Available at: http://www.who.int/csr/don/2010_02_5/en/index.html (accessed February 2010).
  • Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, . Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361: 1925–34.
  • Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, . Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009;361:1935–44.
  • , Cruz, ATPatel B, Distefano MC, Codispoti CR, Shook JE, Demmler-Harrison GJ, . Outside the box and into thick air: implementation of an exterior mobile pediatric emergency response team for North American H1N1 (swine) influenza virus in Houston, Texas. Ann Emerg Med 2010;55: 23–31.
  • Petrosillo N, Di Bella S, Drapeau CM, Grilli E. The novel influenza A (H1N1) virus pandemic: an update. Ann Thorac Med 2009;4:163–72.
  • Perez-Padilla R, de la Rosa-Zamboni D, de Leon SP, Hernandez M, Quinones-Falconi F, Bautista E, . Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680–9.
  • Opal SM. Coming soon to an ICU near you: severe pandemic influenza in ICU patients in Spain. Crit Care 2009;13:196.
  • Meara MO, Brien AO, Feely E, Conlon M. Influenza A outbreak in a community hospital. Ir Med J 2006;99:175–7.
  • Hansen S, Stamm-Balderjahn S, Zuschneid I, Behnke M, Ruden H, Vonberg RP, . Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 2007;65:348–53.
  • Weinstock DM, Eagan J, Malak SA, Rogers M, Wallace H, Kiehn TE, . Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2002;21: 730–2.
  • Van Voris LP, Belshe RB, Shaffer JL. Nosocomial influenza B virus infection in the elderly. Ann Intern Med 1982;96:153–8.
  • Munoz FM, Campbell JR, Atmar RL, Garcia-Prats J, Baxter BD, Johnson LE, . Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J 1999;18:811–5.
  • Meibalane R, Sedmak GV, Sasidharan P, Garg P, Grausz JP. Outbreak of influenza in a neonatal intensive care unit. J Pediatr 1977;91:974–6.
  • Sagrera X, Ginovart G, Raspall F, Rabella N, Sala P, Sierra M, . Outbreaks of influenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J 2002;21: 196–200.
  • Kempe A, Hall CB, MacDonald NE, Foye HR, Woodin KA, Cohen HJ, . Influenza in children with cancer. J Pediatr 1989;115:33–9.
  • Macias AE, de la Torre A, Moreno-Espinosa S, Leal PE, Bourlon MT, Ruiz-Palacios GM. Controlling the novel A (H1N1) influenza virus: don't touch your face! J Hosp Infect 2009;73:280–91.
  • Harriman K, Rosenberg J, Robinson S, Bernier B, Bentz R, Waller K, . Novel influenza A (H1N1) virus infections among health-care personnel. United States, April–May 2009. MMWR Morb Mortal Wkly Rep 2009;58:641–5.
  • Wicker S, Rabenau HF, Bickel M, Wolf T, Brodt R, Brandt C, . Novel influenza H1N1/2009: virus transmission among health care workers. Dtsch Med Wochenschr 2009;134:2443–6.
  • Chironna M, Tafuri S, Santoro N, Prato R, Germinario CA. A nosocomial outbreak of 2009 pandemic influenza A (H1N1) in a paediatric oncology ward in Italy, October–November 2009. Euro Surveill 2010;15:pii: 19454.
  • Centers for Disease Control and Prevention. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term care facility residents—three States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:74–5.
  • Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, . Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009;324:1557–61.
  • Nishiura H, Wilson N, Baker MG. Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. N Z Med J 2009;122:73–7.
  • Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25:5086–96.
  • Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 2005;23:2251–5.
  • Dharan NJ, Patton M, Siston AM, Morita J, Ramirez E, Wallis TR, . Outbreak of antiviral drug-resistant influenza A in long-term care facility, Illinois, USA, 2008. Emerg Infect Dis 2009;15:1973–6.
  • Maltezou HC. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008;21:337–43.
  • Salgado CD, Giannetta ET, Hayden FG, Barr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004;25:923–8.
  • Serwint JR, Miller RM. Why diagnose influenza infections in hospitalized pediatric patients? Pediatr Infect Dis J 1993;12: 200–4.
  • Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in healthcare professionals. JAMA 1999;281:908–13.
  • Hospital Influenza Workgroup (Singapore). Management of novel influenza epidemics in Singapore: consensus recommendations from the Hospital Influenza Workgroup (Singapore). Singapore Med J 2009;50:567.
  • Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. Atlanta, GA: CDC; 2009. Available at: http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm (accessed February 2010).
  • Health Protection Agency. Managing influenza-like illness (ILI) in nursing and residential homes during the current influenza pandemic (WHO Phase 6). London: HPA; 2009. Available at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1248940854313 (accessed February 2010).
  • Shine KI, Rogers B, Goldfrank LR. Novel H1N1 influenza and respiratory protection for health care workers. N Engl J Med 2009:361;19.
  • Buxton Bridges C, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003;37:1094–101.
  • Boone SA, Gerba CP. The occurrence of influenza A virus on household and day care center fomites. J Infect 2005;51: 103–9.
  • Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systemic review. BMC Infect Dis 2006;6:130–8.
  • White LF, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M, . Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respi Viruses 2009;3:267–76.
  • Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, . Prevention and control of seasonal influenza with vaccines. MMWR Morb Mortal Wkly Rep 2009;58:1–52.
  • Perez-Trallero E, Pineiro L, Vicente D, Montes M, Cilla G. Residual immunity in older people against the influenza A (H1N1)—recent experience in northern Spain. Euro Surveill 2009;14:pii: 19344.
  • National Center for Immunization and Respiratory Diseases, CDC. Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009;58:1100–1.
  • Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A (H1N1) 2009 vaccines in the European Union. Euro Surveill 2009;14:pii: 19361.
  • Centers for Disease Control and Prevention. Update: influenza activity—United States, August 30, 2009–January 9, 2010. MMWR Morb Mortal Wkly Rep 2010;59:38–42.
  • Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, . Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945–52.
  • Witkop CT, Duffy MR, Macias EA, Gibbons TF, Escobar JD, Burwell KN, . Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy. Epidemiology and viral shedding duration. Am J Prev Med 2010;38:121–6.
  • Englund J, Zerr D, Heath J, Pergam S, Kuypers J, Yager J, . Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients—Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009;58:893–6.
  • American Academy of Pediatrics. Novel influenza A (H1N1) and children with underlying medical conditions. AAP Work group clarifies children at higher risk. September 29, 2009. Available at: http://aapkansas.org/content/AAPWorkGroupCSHCNH1N1FINAL9.29.09.pdf, last accessed: February 13, 2010.
  • Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M. Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control 1989;17:202–7.
  • Cooley P, Lee BY, Brown S, Cajka J, Chasteen B, Ganapathi L, . Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respi Viruses 2010;4:61–72.
  • Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, . Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine—preliminary report. N Engl J Med 2009;361:1925–34.
  • Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, . Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine—preliminary report. N Engl J Med 2009;361:2424–35.
  • Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulate with or without AS03(A)-adjuvant: preliminary report of an observer-blind, randomized trial. Vaccine 2010;28:1740–5.
  • Daugherty EL, Branson RD, Deveraux A, Rubinson L. Infection control in mass respiratory failure: preparing to respond to H1N1. Crit Care Med 2009 [Epub ahead of print].
  • Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, . Guillain–Barré syndrome following influenza vaccination. JAMA 2004;292:2478–81.
  • Chor JS, Ngai KL, Goggins WB, Wong MC, Lee N, Leung TF, . Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. BMJ 2009;339: b3391.
  • Maurer J, Harris KM, Parker A, Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. Vaccine 2009;27:5732–4.
  • Maltezou HC, Maragos A, Katerelos P, Paisi A, Karageorgou K, Papadimitriou T, . Influenza vaccination acceptance among health-care workers: a nationwide survey. Vaccine 2008;26:1408–10.
  • Bautista D, Vila B, Uso R, Tellez M, Zanon V. Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers. Infect Control Hosp Epidemiol 2006;27:73–7.
  • Dunais B, Saccomano C, Mousnier A, Roure MC, Dellamonica P, Roger PM. Influenza vaccination: impact of an intervention campaign targeting hospital staff. Infect Control Hosp Epidemiol 2006;27:529–31.
  • Song JY, Park CW, Jeong HW, Cheong HJ, Kim WJ, Kim SR. Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2006;27: 612–7.
  • Piccirillo B, Gaeta T. Survey on use of and attitudes toward influenza vaccination among emergency department staff in a New York metropolitan hospital. Infect Control Hosp Epidemiol 2006;27:618–22.
  • Cowan AE, Winston CA, Davis MM, Wortley PM, Clark SJ. Influenza vaccination status and influenza-related perspectives and practices among US physicians. Am J Infect Control 2006;34:164–9.
  • Maltezou HC, Maragos A, Halcharapi T, Karagiannis I, Karageorgou K, Remoudaki H, . Factors influencing influenza vaccination among health-care workers in Greek hospitals. J Hosp Infect 2007;66:156–9.
  • Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ. Influenza vaccine coverage among healthcare workers in Victorian public hospitals. Med J Aust 2007;186:185–6.
  • Walker FJ, Singleton JA, Lu P, Wooten KG, Strikas RA. Influenza vaccination of healthcare workers in the United States, 1989–2002. Infect Control Hosp Epidemiol 2006;27:257–65.
  • Maltezou HC, Maragos A, Raftopoulos V, Karageorgou K, Halharapi T, Remoudaki H, . Strategies to increase influenza vaccine uptake among health-care workers in Greek hospitals. Scand J Infect Dis 2008;40:266–8.
  • Sartor C, Tissot-Dupont H, Zandotti C, Martin F, Roques P, Drancourt M. Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 2004;25:918–22.
  • Borlaug G, Newman A, Pfister J, Davis JP. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005–2006 influenza season. Infect Control Hosp Epidemiol 2007;28:1398–400.
  • Bose ME, Beck ET, Ledeboer N, Kehl SC, Jurgens LA, Patitucci T, . Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol 2009;47:2779–86.
  • He J, Bose ME, Beck ET, Fan J, Tiwari S, Metallo J, . Rapid multiplex reverse transcription-PCR typing of influenza A and B virus and subtyping of influenza A virus into H1,2,3,5,7,9,N1 (human), N1 (animal), N2 and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 outbreak in Milwaukee, Wisconsin. J Clin Microbiol 2009;47:2772–8.
  • Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, . Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009;45:191–5.
  • Balish A, Warnes CM, Wu K, Barnes N, Emery S, Berman L, . Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus—United States, 2009. MMWR Morb Mortal Wkly Rep 2009;58:826–9.
  • Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:728–9.
  • Panning M, Eickmann M, Landt O, Monazahian M, Olschlager S, Baumgarte S, . Detection of influenza A (H1N1)v virus by real-time RT-PCR. Euro Surveill 2009;14: pii:19329.
  • Mahony JB, Hatchette T, Ojkic D, Drews SJ, Gubbay J, Low DE, . Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza. J Clin Virol 2009;45:200–2.
  • World Health Organization. Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenza-like illness. Interim guidance. Geneva: WHO; 2009.
  • Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PD, . Efficacy of soap and water and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 2009;48:285–91.
  • Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, . Mechanisms of the action of povidone–iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J 2009;6:124.
  • Kawana R, Kitamura T, Nagagomi O, Matsumoto I, Arita M, Yoshihara N, . Inactivation of human viruses by povidone–iodine in comparison with other antiseptics. Dermatol 1997;195(Suppl 2):29–35.
  • Radonovich LJ, Perl TM, Davev V, Cohen H. Preventing the soldiers of health care from becoming victims on the pandemic battlefield: respirators or surgical masks as the armor of choice. Disaster Med Public Health Prep 2009;3(Suppl 2):S203–10.
  • Mermel LA. Preventing the spread of influenza A H1N1 2009 to healthcare workers. Lancet Infect Dis 2009;9:723–4.
  • Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, . Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009;302:1865–71.
  • Maltezou HC, Tsiodras S. Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options. Current Drug Targets 2009;10:1041–8.
  • Birnkrant D, Cox E. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009;361:2204–7.
  • Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 2009;83:10366–73.
  • Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM, . Triple combination of oseltamivir, amantadine and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agent Chemother 2009;53:4115–26.
  • Chen H, Cheung CL, Tai H, Zhao P, Chan JF, Cheng VC, . Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009;15: 1970–2.
  • Centers for Disease Control and Prevention. Oseltamivir resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving oseltamivir prophylaxis—North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009;58:969–72.
  • Centers for Disease Control and Prevention. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:433–5.
  • Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, . Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochem Biophys Res Commun 2009;385:390–4.
  • Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season. December 7, 2009. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm, last accessed: February 13, 2010.
  • Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009;361:2296–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.